Wave Life Sciences (WVE) Preferred Stock Liabilities (2015 - 2025)

Wave Life Sciences' Preferred Stock Liabilities history runs 11 years deep, the most recent figure standing at $7.9 million for Q4 2025.

• Quarterly Preferred Stock Liabilities changed 0.0% year-over-year to $7.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $7.9 million (changed 0.0% YoY) and the FY2025 annual result came in at $7.9 million, changed 0.0% from the prior year.
• Preferred Stock Liabilities was $7.9 million for Q4 2025 at Wave Life Sciences, roughly flat from $7.9 million in the prior quarter.
• Across five years, Preferred Stock Liabilities topped out at $7.9 million in Q1 2021 and bottomed at $7.9 million in Q1 2021.
• A 5-year average of $7.9 million and a median of $7.9 million in 2021 frame the typical range for Preferred Stock Liabilities.
• Peak annual rise in Preferred Stock Liabilities reached 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
• Wave Life Sciences' Preferred Stock Liabilities stood at $7.9 million in 2021, then changed by 0.0% to $7.9 million in 2022, then changed by 0.0% to $7.9 million in 2023, then changed by 0.0% to $7.9 million in 2024, then changed by 0.0% to $7.9 million in 2025.
• Business Quant data shows WVE's Preferred Stock Liabilities at $7.9 million in Q4 2025, $7.9 million in Q3 2025, and $7.9 million in Q2 2025.